| scholarly article | Q13442814 |
| P2093 | author name string | L A Bobek | |
| H Tsai | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans | Q24297832 | ||
| Candidacidal activity of recombinant human salivary histatin-5 and variants | Q24679661 | ||
| Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus | Q35137093 | ||
| In vitro models for studying toxicity of antifungal agents | Q35447528 | ||
| Oral candidiasis | Q35720191 | ||
| Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae | Q36463806 | ||
| Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins | Q36745984 | ||
| Anticandidal activity of major human salivary histatins | Q36966811 | ||
| Isolation of milligram quantities of a group of histidine-rich polypeptides from human parotid saliva. | Q37085635 | ||
| Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans | Q37085706 | ||
| Anti-Candida drugs--the biochemical basis for their activity | Q39685115 | ||
| The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans | Q39784510 | ||
| Polyacrylamide Gel Electrophoresis of Human Salivary Histidine-Rich-Polypeptides | Q40508721 | ||
| Oral Candida: clearance, colonization, or candidiasis? | Q40550395 | ||
| Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands | Q41149024 | ||
| Site-directed mutagenesis of virtually any plasmid by eliminating a unique site | Q42611278 | ||
| Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis | Q47736954 | ||
| Longitudinal study of parotid saliva in HIV-1 infection | Q67559317 | ||
| Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity | Q68027948 | ||
| One-step purification of histidine-rich polypeptides form human parotid saliva and determination of anti-candidal activity | Q68049300 | ||
| Antifungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates | Q68049302 | ||
| In vitro susceptibility of Candida species to lysozyme | Q68108351 | ||
| Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity | Q68929515 | ||
| A comparison of the inhibition of blastospore viability and germ-tube development in Candida albicans by histidine peptides and ketoconazole | Q70266859 | ||
| Computed circular dichroism spectra for the evaluation of protein conformation | Q71225133 | ||
| Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity | Q71433553 | ||
| The emerging fungal threat | Q72124266 | ||
| Histatin as a synergistic stimulator with epidermal growth factor of rabbit chondrocyte proliferation | Q72733083 | ||
| Interactions between denture lining material, protein pellicles and Candida albicans | Q72918614 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2224-2228 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species | |
| P478 | volume | 41 |
| Q39470384 | Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides |
| Q34516733 | Anti-candidal activity of genetically engineered histatin variants with multiple functional domains |
| Q90193669 | Antimicrobial Activity, Antioxidant Potential, Cytotoxicity and Phytochemical Profiling of Four Plants Locally Used against Skin Diseases |
| Q36757536 | Candida albicans flu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentration and fungicidal activity |
| Q33927464 | Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37 |
| Q33721804 | Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. |
| Q90131602 | Digital Design of a Universal Rat Intraoral Device for Therapeutic Evaluation of a Topical Formulation against Candida-Associated Denture Stomatitis |
| Q73233559 | Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7 |
| Q73930216 | Effect of donor age on the concentrations of histatins in human parotid and submandibular/sublingual saliva |
| Q34775235 | Fungal infections associated with HIV infection |
| Q33977671 | Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization |
| Q37643080 | Histatin peptides: Pharmacological functions and their applications in dentistry |
| Q35006531 | Human salivary histatin 5 fungicidal action does not induce programmed cell death pathways in Candida albicans |
| Q42546556 | Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans |
| Q41125894 | Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals |
| Q33979652 | In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. |
| Q29871517 | MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action |
| Q31137858 | Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma |
| Q38684267 | Potassium and Sodium Transport in Yeast |
| Q34067033 | Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection |
| Q33980976 | Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. |
| Q37219481 | Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine |
| Q91386288 | Specific metallo-protein interactions and antimicrobial activity in Histatin-5, an intrinsically disordered salivary peptide |
| Q34722920 | Susceptibility of Candida dubliniensis to salivary histatin 3. |
| Q36424968 | The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding |
| Q26859136 | The oral microbiome and the immunobiology of periodontal disease and caries |
Search more.